Cargando…
Elevated HDAC activity and altered histone phospho-acetylation confer acquired radio-resistant phenotype to breast cancer cells
BACKGROUND: Poor-responsiveness of tumors to radiotherapy is a major clinical problem. Owing to the dynamic nature of the epigenome, the identification and targeting of potential epigenetic modifiers may be helpful to curb radio-resistance. This requires a detailed exploration of the epigenetic chan...
Autores principales: | Sharda, Asmita, Rashid, Mudasir, Shah, Sanket Girish, Sharma, Ajit Kumar, Singh, Saurav Raj, Gera, Poonam, Chilkapati, Murali Krishna, Gupta, Sanjay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942324/ https://www.ncbi.nlm.nih.gov/pubmed/31900196 http://dx.doi.org/10.1186/s13148-019-0800-4 |
Ejemplares similares
-
In-Silico Analysis of Chromatin Modifiers and Profiling of Histone Deacetylases (HDAC's) in Human Oral Cancer
por: Sajnani, Anand K., et al.
Publicado: (2021) -
Host histone acetylation unlocks HDAC inhibitor potential
por: Terranova-Barberio, Manuela, et al.
Publicado: (2017) -
Hepcidin is regulated by promoter-associated histone acetylation and HDAC3
por: Pasricha, Sant-Rayn, et al.
Publicado: (2017) -
Histone deacetylase (HDAC) 1 and 2 complexes regulate both histone acetylation and crotonylation in vivo
por: Kelly, R. D. W., et al.
Publicado: (2018) -
Expression of acetylated histones H3 and H4 and histone deacetylase enzymes HDAC1, HDAC2 and HDAC6 in simple mammary carcinomas of female dogs
por: Senhorello, Igor Luiz Salardani, et al.
Publicado: (2023)